Demographic and clinical characteristics |
MS patients |
N = 120 |
Gender ratio (M:F) |
1:1.72 (44:76) |
Age at onset, years, mean ± SD (range) |
30.86 ± 7.92 (16 - 55) |
Disease course: |
Relapsing-remitting |
60 (50.0%) |
Secondary-progressive |
48 (40.0%) |
Primary-progressive |
12 (10.0%) |
Duration of the symptoms, years, mean, ± SD |
11.93 ± 8.0 |
Duration of the disease (time of diagnosis), years, mean± SD |
6.84 ± 3.54 |
Relapse rate per year, mean ± SD |
1.36 ± 0.88 |
EDSSA score, mean ± SD |
4.26 ± 2.01 |
EDSSB score, mean ± SD |
3.8 ± 1.0 |
Patients with positive OCBs (n, %) |
88 (73.3%) |
Demographic and clinical characteristics |
MS patients |
N = 120 |
Gender ratio (M:F) |
1:1.72 (44:76) |
Age at onset, years, mean ± SD (range) |
30.86 ± 7.92 (16 - 55) |
Disease course: |
Relapsing-remitting |
60 (50.0%) |
Secondary-progressive |
48 (40.0%) |
Primary-progressive |
12 (10.0%) |
Duration of the symptoms, years, mean, ± SD |
11.93 ± 8.0 |
Duration of the disease (time of diagnosis), years, mean± SD |
6.84 ± 3.54 |
Relapse rate per year, mean ± SD |
1.36 ± 0.88 |
EDSSA score, mean ± SD |
4.26 ± 2.01 |
EDSSB score, mean ± SD |
3.8 ± 1.0 |
Patients with positive OCBs (n, %) |
88 (73.3%) |
SD - standard deviation, EDSS - Expanded Disability Status Scale, EDSSA - EDSS score during last visit, EDSSB - EDSS score at time of diagnosis, OCBs- oligoclonal bands. |
|